ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team 06 Mar 2024 A global, interdisciplinary team of researchers has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the challenge of solid tumours in children. Find out more Show/Hide
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace 22 Feb 2024 Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme. Find out more Show/Hide
ICR welcomes FDA approval of first-in-class breast cancer drug 17 Nov 2023 The ICR strongly welcomes the news that a new targeted drug, capivasertib, has been approved by the US FDA for treating the most common type of advanced breast cancer. The drug was discovered by pharmaceutical company AstraZeneca following a programme of drug discovery research at the ICR in collaboration with Astex Pharmaceuticals. Find out more Show/Hide
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration 04 May 2023
Researchers discover potential new series of cancer drugs targeting cancer-driving protein BCL6 09 Feb 2023